NCT00428233
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Clinical trial condition
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
NCT00428233
NCT01497093
NCT00857389
NCT00889031
NCT00853008
NCT00049075
NCT01356680
NCT01087008
NCT00003687